0.1% Atropine drops. Reduces myopia progression by 60-87%
OrthoKeratology Reduces myopia progression by at least 40%-??%
Soft multifocal contact lenses Reduces myopia progression by 40-87%
Time outdoors, limited outdoor time continues to be a risk factor. 2 hours a day is the goal.
Further Explanation on Treatment Options
As consumer awareness increases about the growing incidence of myopia, the FDA approved treatment option of ortho-k could meet your patient’ s visual requirements and improve their quality of life.
Orthokeratology is ideal for:
-Kids and teens with active lifestyle who may be concerned about their prescription increasing year after year. Or those interested in freedom from the hassle of discomfort of day time contact lenses.
-Parents concerned about their children breaking or losing their contacts or glasses while at school or play. Parents appreciate being able to supervise their child’s wearing schedule each evening, which ensure they wake up with great vision each day.
-Adults suffering from dry eye or uncomfortable soft contact lenses, or those who have dropped out of contact lenses all together. We can reassure parents that orthokeratology is safe and effective. Of the millions of patients using this modality for myopia correction since its FDA approval in 2002, only nine (9) adverse events have been reported to the FDA – all of which were resolved.
Multifocal Contact Lenses
Several studies in the past five years have shown that soft multifocal contact lenses with a center distance design can slow the development of myopia as well as elongation of the eye.
Multifocal contact lenses are thought to work for preventing myopic progression because they focus light in front of the peripheral retina, which prevents the elongation of the eye (increasing myopia), and they focus light right on the retina, which still provides people with clear vision.
Atropine is a cholinergic antagonist in the same family as the drops used to dilate the eyes. In low concentrations, atropine has been shown to significantly reduce myopic progression with very few side effects Limited to glare from slightly larger pupil size. The lower concentrations have limited effect on the pupil size and the ability focus allowing children to go about their normal activities. Atropine is a long acting medication, successful treatment has been achieved with as little as one drop per week.